Reported 636,364 shares, unchanged from the prior quarter.
Reported value -35.8%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-03-31 | 2157274 |
| 2025-06-30 | 1724546 |
| 2025-09-30 | 1648183 |
| 2025-12-31 | 960910 |
| 2026-03-31 | 1960001 |
| 2026-06-30 | 2507274 |
| 2026-09-30 | 1610001 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 636,364 | 0 (0.0%) | 1.12% | $1,610,001 | 2026-11-13 | |
| Q2 2026 | Unchanged | 636,364 | 0 (0.0%) | 2.4% | $2,507,274 | 2026-08-14 | |
| Q1 2026 | Unchanged | 636,364 | 0 (0.0%) | 1.34% | $1,960,001 | 2026-05-15 | |
| Q4 2025 | Unchanged | 636,364 | 0 (0.0%) | 0.4% | $960,910 | 2026-02-13 | |
| Q3 2025 | Unchanged | 636,364 | 0 (0.0%) | 0.78% | $1,648,183 | 2025-11-14 | |
| Q2 2025 | Unchanged | 636,364 | 0 (0.0%) | 1.09% | $1,724,546 | 2025-08-14 | |
| Q1 2025 | New | 636,364 | +636,364 (0.0%) | 1.45% | $2,157,274 | 2025-05-14 |
Who else reported the position
180 managers reported ELEDON PHARMACEUTICALS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 6,641,297 | +1,517,455 | < 0.01% | $16,802,480 | 9 qtrs |
| BVF INC IL | Unchanged | 6,293,282 | 0 | 0.52% | $15,922,003 | 23 qtrs |
| Defilade Capital Management L P | Unchanged | 3,525,338 | 0 | 1.49% | $8,919,105 | 4 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Unchanged | 3,417,223 | 0 | < 0.01% | $8,645,574 | 3 qtrs |
| The Goldman Sachs Group Inc | Added | 2,561,285 | +50,977 | < 0.01% | $6,480,051 | 8 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 1,980,977 | +24,376 | < 0.01% | $5,013,079 | 23 qtrs |
| Ensign Peak Advisors Inc | Reduced | 1,756,223 | -345,001 | < 0.01% | $4,443,244 | 24 qtrs |
| Catalio Capital Management LP | Reduced | 1,637,114 | -57,957 | 0.77% | $4,141,898 | 5 qtrs |
| STATE STREET CORPORATION | Reduced | 1,614,898 | -7,071 | < 0.01% | $4,085,692 | 22 qtrs |
| SPHERA FUNDS MANAGEMENT LTD | Added | 1,392,187 | +201,000 | 0.5% | $3,522,233 | 10 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 13, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 636,364
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.